Acesso rápido

No journals followed

Browse journals

No saved papers

Política de privacidade

Feed Explorar shellTopNav.journalClub Tendências Perguntas Pesquisadores

⌘K

Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials | Synapse

May 20, 2026

Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials

Key Points

Key points are not available for this paper at this time.

Abstract

This study evaluates the quantile-aggregation method using both simulated data and publicly available Alzheimer disease randomized trial data.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Flanders et al. (Mon,) studied this question.

www.synapsesocial.com/papers/6a0d4ec0f03e14405aa99eae — DOI: https://doi.org/10.1001/jamaneurol.2026.1240

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual‐level data from the A4 study of solanezumab· 2026 · 1 citations
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease· 2025 · 8 citations
Mediation Analysis: A Practitioner's Guide· 2015 · 1,912 citations
Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis· 2021 · 180 citations

Authors

M

Michael D. Flanders

M

Michelle Caunca

R

Renaud La Joie

Journals

JAMA Neurology

Actions

Institutions

University of California, San Francisco

University of Southern California

Brown University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Donanemab in Early Symptomatic Alzheimer Disease· 2023 · 2,415 citations